NCT03623932

Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University Hospital, Grenoble · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Evaluation of hypnosis therapy efficacy in addition to pharmacologic standard treatment of Croh disease during remission by the evaluation of quality of life;

Detailed description

Crohn disease is defined as an inflammatory chronic disease of the bowel characterize by intermittent flare-ups and remission periods. Crohn disease is due to genetic and environmental factors such as stress. Stress is an important aggravation factor of the disease symptoms which can stop a remission period and induce a relapse into a flare-up period. Hypnosis is a non-medicinal technic which already show efficacy in the treatment of functional digestive troubles. These diseases are bio/psycho/social models such as Crohn disease. Hypnosis can reduce visceral pain sensibility, reduce stress and reduce pro-inflammatory cytokines liberation into intestinal mucosa. Though, only few data are available on hypnosis interest in the treatment of Crohn disease and inflammatory bowel diseases as it is often isolated clinical case report. One study on patients with rectocolitis in remission period has been done recently and show that hypnosis increased the duration of the remission period. The principal objective of this study is to evaluate hypnosis efficacy in term of quality of life for patients with Crohn disease during remission.

Conditions

• Crohn Disease

Interventions

Type	Name	Description
DRUG	immunosuppressor/TNFalpha	Standard Treatment : immunosuppressor/TNFalpha as in standard practice
BEHAVIORAL	Hypnosis	8 hypnosis group sessions during 2 months

Timeline

• Start date: 2018-11-13
• Primary completion: 2021-11-12
• Completion: 2021-11-13
• First posted: 2018-08-09
• Last updated: 2020-03-23

Locations

1 site across 1 country: France